Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

1-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-3-(3-fluorophenyl)urea

EU orphan designation number: EU/3/11/915
Active ingredient: 1-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-3-(3-fluorophenyl)urea
Indication: Treatment of acute myeloid leukaemia
Sponsor: AbbVie Ltd
Maidenhead, SL6 4UB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/10/2011 Orphan designation EMA/OD/067/11 (2011)7893 of 27/10/2011
01/02/2013 Transfer of orphan designation EMA/OD/067/11/T/01 (2013)599 of 30/01/2013
22/04/2015 Removal of orphan designation from Community Register